DC Field | Value | Language |
dc.contributor.author | Revenco, Ninel | |
dc.contributor.author | Cracea, Angela | |
dc.contributor.author | Mazur-Nicorici, Lucia | |
dc.contributor.author | Foca, Silvia | |
dc.contributor.author | Eremciuc, Rodica | |
dc.contributor.author | Gaidarji, Olga | |
dc.contributor.author | Iacomi, Vladimir | |
dc.contributor.author | Bogonovschi, Livia | |
dc.date.accessioned | 2024-01-17T13:37:06Z | |
dc.date.available | 2024-01-17T13:37:06Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | REVENCO, Ninel, CRACEA, Angela, MAZUR-NICORICI, Lucia, et al. The clinical and paraclinical efficacy of tocilizumab in juvenile idiopathic arthritis. In: Archives of the Balkan Medical Union. 2021, nr. 2(56), pp. 185-192. ISSN 1584-9244. | |
dc.identifier.issn | 1584-9244 | |
dc.identifier.issn | 2558-815X | |
dc.identifier.uri | https://umbalk.org/wp-content/uploads/2021/06/07.THE-CLINICAL-AND-PARACLINICAL-EFFICACY.pdf | |
dc.identifier.uri | https://doi.org/10.31688/ABMU.2021.56.2.07 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/26740 | |
dc.language.iso | en | en_US |
dc.publisher | Balkan Medical Union | en_US |
dc.relation.ispartof | Archives of the Balkan Medical Union | en_US |
dc.subject | juvenile idiopathic arthritis | en_US |
dc.subject | tocilizumab | en_US |
dc.subject | inflammatory markers | en_US |
dc.title | The clinical and paraclinical efficacy of tocilizumab in juvenile idiopathic arthritis | en_US |
dc.title.alternative | L’efficacité clinique et paraclinique du tocilizumab dans l’arthrite juvénile idiopathique | en_US |
dc.type | Article | en_US |
Appears in Collections: | ARTICOLE ȘTIINȚIFICE
|